A Phase 2b, Extension Study to Determine the Long-term Safety of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease
Phase of Trial: Phase II
Latest Information Update: 08 Jul 2019
Price : $35 *
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions
- Acronyms Hubble zoom
- Sponsors Takeda
- 05 Oct 2018 Status changed from not yet recruiting to recruiting.
- 06 Jun 2018 Planned initiation date changed from 22 May 2018 to 6 Aug 2018.
- 13 Mar 2018 Planned initiation date changed from 1 May 2018 to 22 May 2018.